Chairman of the International Drug Policy Consortium.

Has a wide range of experience in the field of drug treatment and policy, from direct work with problem drug users, to senior positions in national government and international agencies.

After 12 years working in and managing projects that provided treatment to the homeless, drug users and offenders, Mike was offered the post of Deputy UK Anti-Drug Co-ordinator in 1997, and held this post until 2001. His duties included the creation of the UK National Drug Strategy - Tackling Drugs to Build a Better Britain - and the oversight of the first years of its implementation.

From 2000 to 2003, he was the Chair of the European Union drugs agency, the European Monitoring Centre on Drugs and Drug Addiction, where he was responsible for steering the 3 year work plan of the agency on behalf of the EU Member States, which involved the collation and dissemination of research and analysis on drug use, problems and responses across Europe. From 2001 to 2002, Mike held the post of Director of Performance at the National Treatment Agency, set up by the UK government to oversee the rapid expansion of the drug treatment sector.

In 2002, he left to take up the post of Chief, Demand Reduction Section at the United Nations Office on Drugs and Crime in Vienna. Since leaving his United Nations post, Mike has returned to the UK and the non-governmental sector. After a year as Chief Executive of The Blenheim Project, a provider of community treatment services in London, he moved in 2004 to become Chief Executive of RAPT, one of the biggest providers of drug treatment services in the UK prison system. Mike splits his time between this role, and his role as Chair of IDPC, where he contributes to IDPC strategy, representation, fundraising and organisational development.